You are viewing: Europe Periodontal Disease Treatment Market analysis

The Europe Periodontal Disease Treatment Market was valued at $942.2 Million in 2024 and projected to reach to $1239.4 Million by 2029, representing a compound annual growth rate of 4.7%. Europe's periodontal disease treatment market is positioned for steady expansion through 2029, driven by an aging population with increasing oral health awareness and rising prevalence of periodontal conditions.

Europe Periodontal Disease Treatment Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Periodontal Disease Treatment Market Trends and Insights

  • This steady expansion reflects Europe's aging population, rising prevalence of periodontal conditions, and increasing adoption of advanced treatment technologies across the region.
  • Europe maintains a mature healthcare infrastructure with strong regulatory frameworks that support innovation in dental therapeutics and surgical interventions. The European market benefits from high healthcare spending, widespread dental insurance coverage, and growing patient awareness of oral health's systemic implications.
  • Europe's emphasis on preventive care and minimally invasive procedures is driving demand for specialized periodontal treatments, including laser therapy, bone grafting, and regenerative solutions.
  • Between 2024 and 2029, Europe is expected to see accelerated investment in digital dentistry and implant-based therapies, positioning the region as a key growth driver within the global periodontal treatment landscape..

Key Market Statistics

  • CAGR (2024-2029) 4.7% CAGR
  • Market Size, 2024 ~USD 942.2 Million
  • Forecast, 2029 ~USD 1239.4 Million
  • Geography Europe

Europe Periodontal Disease Treatment Market Overview

Mature Market with Steady Growth :

Europe's periodontal disease treatment market valued at $942.2 million in 2024, expanding at 4.7% CAGR through 2029, reflecting a mature healthcare landscape with consistent demand for advanced periodontal solutions.

Aging Population Driving Demand :

Europe's aging demographic significantly increases periodontal disease prevalence, creating sustained demand for preventive and therapeutic treatment options across dental practices and specialized clinics.

Advanced Technology Adoption :

European healthcare systems demonstrate strong adoption of cutting-edge periodontal technologies including laser therapy, regenerative procedures, and digital diagnostics, supporting market expansion.

Regional Market Leadership :

Key European markets including UK ($124.38M), Italy ($196.42M), and Spain ($153.67M) lead regional growth, supported by robust healthcare infrastructure and high treatment accessibility standards.

Europe Periodontal Disease Treatment Market Dynamics

  • The region's mature healthcare infrastructure and strong regulatory frameworks support the adoption of advanced treatment technologies, including minimally invasive procedures and regenerative therapies.
  • Healthcare providers across Europe are increasingly investing in specialized periodontal services to address growing patient demand. The market outlook remains positive with forecasted growth to $1,239.4 million by 2029.
  • Key growth drivers include enhanced reimbursement policies, growing dental tourism, and increased collaboration between general dentists and periodontists.
  • European countries' emphasis on preventive care and early intervention strategies will continue to support market expansion, though growth rates remain moderate compared to emerging markets due to market maturity..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Europe's periodontal disease treatment market is valued at $942.2 million in 2024 and will reach $1,239.4 million by 2029, representing a 4.7% CAGR.
      • Europe's mature healthcare infrastructure and high dental insurance penetration support sustained demand for advanced periodontal therapies.
      • Aging demographics and increased awareness of periodontal disease's link to systemic health are key growth drivers across Europe.
      • Digital dentistry, regenerative treatments, and minimally invasive procedures are reshaping Europe's periodontal treatment landscape through 2029.

      Periodontal Disease Treatment Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment AGGRESSIVE PERIODONTITIS (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 5.9% from 2024 to 2029
      Largest Segment NON-SURGICAL TREATMENT (Treatment)
      Market Size Base Year (Billions) ~USD 2.57 (2024)
      Revenue Forecast (Billions) ~USD 3.43 (2029)
      Segments Covered Product, Disease, Type, Treatment

      Europe Periodontal Disease Treatment Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Consumables
      • Equipment
      • Medication

      By Disease

      • Aggressive Periodontitis
      • Chronic Periodontitis
      • Gingivitis
      • Other Diseases

      By Type

      • Acute Gingivitis
      • Chronic Gingivitis
      • Medication Therapy
      • Recurrent Gingivitis
      • Root Planing
      • Scaling

      By Treatment

      • Bone Grafting
      • Flap Surgery/Pocket Reduction Therapy
      • Guided Tissue Regeneration
      • Non-Surgical Treatment
      • Other Treatments
      • Soft Tissue Graft

      Target Audience

      • Dental Device Manufacturers : Manufacturers need Europe-specific market data to develop localized product strategies, understand regulatory pathways, and identify distribution opportunities across diverse European healthcare systems.
      • Periodontal Treatment Providers : Dental clinics and periodontists require market insights to benchmark performance, identify growth opportunities, and make informed decisions about service expansion and technology investments.
      • Healthcare Investors & PE Firms : Investment professionals need detailed European market analysis to evaluate acquisition targets, assess growth potential, and identify consolidation opportunities in the periodontal treatment sector.
      • Pharmaceutical & Biotech Companies : Companies developing periodontal therapeutics need regional market data to guide clinical trial planning, commercialization strategies, and reimbursement negotiations across European markets.
      • Healthcare Consultants & Advisors : Consulting firms require comprehensive Europe-specific market intelligence to support client strategy development, market entry planning, and competitive positioning recommendations.

      Key Companies in the Europe Periodontal Disease Treatment Market

      CompanyHQOwnershipStrongest segments
      DENTSPLY SIRONAUnited StatesPublic CompanyConnected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions,
      ENVISTA HOLDINGS CORPORATIONUnited StatesPublic CompanySpecialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization,
      HENRY SCHEIN, INC.United StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      BIOLASE, INC.United StatesPublic CompanyWaterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces,
      NAKANISHI INC.JapanPublic CompanyDental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products,
      A-DEC INC.SwitzerlandPublic CompanyFlexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting,

      DENTSPLY SIRONA

      DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.

      ENVISTA HOLDINGS CORPORATION

      ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.

      HENRY SCHEIN, INC.

      HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.

      BIOLASE, INC.

      BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.

      NAKANISHI INC.

      NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.

      A-DEC INC.

      A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 1113.2 Million · 6.2% wtd CAGR ·
      Asia Pacific
      ~USD 851.6 Million · 6.9% wtd CAGR ·
      Middle East & Africa
      ~USD 126 Million · 7.8% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 87.86 Million
      FranceUSD 54.73 Million
      UKUSD 124.38 Million
      ItalyUSD 196.42 Million
      SpainUSD 153.67 Million
      Rest Of EuropeUSD 54.15 Million

      Country market size visualization

      Germany
      USD 87.86 Million
      France
      USD 54.73 Million
      UK
      USD 124.38 Million
      Italy
      USD 196.42 Million
      Spain
      USD 153.67 Million
      Rest Of Europe
      USD 54.15 Million

      Reasons to Buy this Report

      • Country-Level Market Segmentation : Access detailed market sizing for major European countries including UK, Germany, France, Italy, and Spain, enabling targeted market entry and expansion strategies specific to regional healthcare dynamics.
      • Growth Trajectory Insights : Understand Europe's 4.7% CAGR growth pattern through 2029, identifying market maturity levels and investment opportunities across different European segments and healthcare systems.
      • Competitive Landscape Analysis : Gain intelligence on regional competitive positioning, technology adoption rates, and market consolidation trends specific to European periodontal treatment providers and manufacturers.
      • Regulatory & Reimbursement Framework : Comprehensive analysis of European healthcare regulations, reimbursement policies, and compliance requirements that impact market access and pricing strategies across different countries.
      • Strategic Market Positioning : Identify high-growth sub-segments and underserved markets within Europe to optimize product development, partnership strategies, and resource allocation for maximum market penetration.

      Frequently asked questions

      What is the current size of Europe's periodontal disease treatment market?

      Europe's periodontal disease treatment market was valued at $942.2 million in 2024 and is expected to grow to $1,239.4 million by 2029.

      What is the projected growth rate for Europe's periodontal treatment market?

      Europe's periodontal disease treatment market is projected to grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2029.

      What factors are driving growth in Europe's periodontal treatment market?

      Key drivers include Europe's aging population, rising prevalence of periodontal disease, increased healthcare spending, widespread dental insurance coverage, and growing adoption of advanced treatment technologies such as laser therapy and regenerative procedures.

      Which treatment modalities are gaining traction in Europe's periodontal market?

      Europe is seeing increased adoption of minimally invasive procedures, digital dentistry solutions, laser-based therapies, bone grafting, implant-based treatments, and regenerative periodontal therapies.

      How does Europe's market compare to global periodontal treatment trends?

      Europe's 4.7% CAGR is slightly lower than the global 5.9% CAGR, reflecting Europe's mature market status; however, Europe maintains higher per-capita spending and more advanced treatment adoption rates than many other regions.

      RESEARCH METHODOLOGY

      Get the Full Periodontal Disease Treatment Market Report

      Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status